Research.Patient.info

Myelodysplastic syndrome (MDS), Acute Myeloid Leukemia (AML) research hub

1 indexed studies · 0 currently recruiting

ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
A first-in-human, Phase 1, Dose Escalation Study of SGR-2921 as Monotherapy in subjects with relapsed/refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
This study is testing a new medicine, SGR-2921, for the first time in people. It's for adults with certain blood cancers, Acute Myeloid Leukaemia (AML) or Myelodysplastic Syndrome (MDS), who haven't responded to previous treatments. Researchers want to find a safe dose.
Spain · France